Abstract

K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study

Author(s): Kumaravelrajan Rajagopal, Arockiyasamy Kishore metha, Venkatesan Suba, Thiraviam Purushoth Prabhu

Issue: Jan/Feb 2025 - Volume 29, Number 1

Page(s): 14-21

Download in electronic PDF format for $75
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 1
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 2
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 3
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 4
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 5
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 6
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 7
  • K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 8

Abstract

This study investigates the potential of using kappa-carrageenan and hydroxypropylated tapioca starch as alternatives to traditional gelatin capsules in pharmaceutical applications. Nine formulations are developed and optimized based on viscosity, appearance, and loss on drying. The process involves a rotary die method for encapsulation, followed by characterization including SEM analysis, moisture content, and stability assessment. The optimized formulation (F8) demonstrates clear description, appropriate viscosity (11035 cps), and acceptable loss on drying (33.5%). Physical characterization reveals consistent capsule dimensions and moisture content within acceptable ranges. Disintegration and drug release studies indicate promising performance, with capsules dissolving within 15 minutes and achieving 99.23% drug release in 60 minutes. Stability testing confirms the suitability of the optimized formulations for pharmaceutical use.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2025
Pg. 14-21
Jul/Aug 1999
Pg. 291-294
Author(s): Allen Loyd V Jr
Mar/Apr 2008
Pg. 163-169
Jul/Aug 2021
Pg. 304-309
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 209-214
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 434-437
Mar/Apr 2020
Pg. 98-102
Author(s): Riepl Mike
May/Jun 2004
Pg. 181-185
Mar/Apr 2021
Pg. 104-108
Jan/Feb 2022
Pg. 58-64
Jul/Aug 2022
Pg. 283-291
Mar/Apr 2009
Pg. 170-174
Mar/Apr 2017
Pg. 171-175
Mar/Apr 2002
Pg. 155-157
Sep/Oct 2001
Pg. 389-390
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 143
Author(s): Allen Loyd V Jr
Sep/Oct 1999
Pg. 396
Author(s): Allen Loyd V Jr
May/Jun 1997
Pg. 187
Author(s): Allen Loyd V Jr
May/Jun 1999
Pg. 232-233
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 312-313
Author(s): Allen Loyd V Jr